-
Add to Cart The item has been addedH649282-25mgHonokiol DCA (Honokiol dichloroacetate) is a dichloroacetate analog of Honokiol. Honokiol DCA can inhibit the growth of human prostate cancer cells in vitro and suppress the androgen receptor (AR) protein level.In VitroHonokiol DCA (20-40 μM: 24-48 -
Add to Cart The item has been addedH649282-50mgHonokiol DCA (Honokiol dichloroacetate) is a dichloroacetate analog of Honokiol. Honokiol DCA can inhibit the growth of human prostate cancer cells in vitro and suppress the androgen receptor (AR) protein level.In VitroHonokiol DCA (20-40 μM: 24-48 -
Add to Cart The item has been addedH649282-5mgHonokiol DCA (Honokiol dichloroacetate) is a dichloroacetate analog of Honokiol. Honokiol DCA can inhibit the growth of human prostate cancer cells in vitro and suppress the androgen receptor (AR) protein level.In VitroHonokiol DCA (20-40 μM: 24-48 -
Add to Cart The item has been addedH655785-1mlHonokiol DCA (Honokiol dichloroacetate) is a dichloroacetate analog of Honokiol. Honokiol DCA can inhibit the growth of human prostate cancer cells in vitro and suppress the androgen receptor (AR) protein level.In VitroHonokiol DCA (20-40 μM: 24-48 -
Add to Cart The item has been addedH651178-10mgHPK1-IN-19 is a hematopoietic progenitor kinase 1 (HPK1) inhibitor extracted from patent WO2018102366A1 compound I-47Form:SolidIC50&: Target:hematopoietic progenitor kinase 1 (HPK1). -
Add to Cart The item has been addedH651178-25mgHPK1-IN-19 is a hematopoietic progenitor kinase 1 (HPK1) inhibitor extracted from patent WO2018102366A1 compound I-47Form:SolidIC50&: Target:hematopoietic progenitor kinase 1 (HPK1). -
Add to Cart The item has been addedH651178-50mgHPK1-IN-19 is a hematopoietic progenitor kinase 1 (HPK1) inhibitor extracted from patent WO2018102366A1 compound I-47Form:SolidIC50&: Target:hematopoietic progenitor kinase 1 (HPK1). -
Add to Cart The item has been addedH651178-5mgHPK1-IN-19 is a hematopoietic progenitor kinase 1 (HPK1) inhibitor extracted from patent WO2018102366A1 compound I-47Form:SolidIC50&: Target:hematopoietic progenitor kinase 1 (HPK1). -
Add to Cart The item has been addedH658896-100mgHPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1: MAP4K1) inhibitor with an IC 50 of 0.25 nM. HPK1-IN-3 has IL-2 cellular potency with an EC 50 of 108 nM in human peripheral blood mononuclear cells -
Add to Cart The item has been addedH658896-10mgHPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1: MAP4K1) inhibitor with an IC 50 of 0.25 nM. HPK1-IN-3 has IL-2 cellular potency with an EC 50 of 108 nM in human peripheral blood mononuclear cells -
Add to Cart The item has been addedH658896-25mgHPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1: MAP4K1) inhibitor with an IC 50 of 0.25 nM. HPK1-IN-3 has IL-2 cellular potency with an EC 50 of 108 nM in human peripheral blood mononuclear cells -
Add to Cart The item has been addedH658896-50mgHPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1: MAP4K1) inhibitor with an IC 50 of 0.25 nM. HPK1-IN-3 has IL-2 cellular potency with an EC 50 of 108 nM in human peripheral blood mononuclear cells
